Terms: = Lymphoma AND IRF4, LSIRF, 3662, ENSG00000137265, Q15306
397 results:
1. STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma.
Prutsch N; He S; Berezovskaya A; Durbin AD; Dharia NV; Maher KA; Matthews JD; Hare L; Turner SD; Stegmaier K; Kenner L; Merkel O; Look AT; Abraham BJ; Zimmerman MW
Cell Rep Med; 2024 Mar; 5(3):101472. PubMed ID: 38508140
[TBL] [Abstract] [Full Text] [Related]
2. Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses.
Shichijo T; Yasunaga JI; Sato K; Nosaka K; Toyoda K; Watanabe M; Zhang W; Koyanagi Y; Murphy EL; Bruhn RL; Koh KR; Akari H; Ikeda T; Harris RS; Green PL; Matsuoka M
Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2309925121. PubMed ID: 38502701
[TBL] [Abstract] [Full Text] [Related]
3. From the archives of MD Anderson Cancer Center: Monomorphic epitheliotropic intestinal T-cell lymphoma: A case with an unusual immunophenotype and discussion of differential diagnosis.
Dcunha NJ; Wei Q; Thakral B; Medeiros LJ
Ann Diagn Pathol; 2024 Jun; 70():152293. PubMed ID: 38484479
[TBL] [Abstract] [Full Text] [Related]
4. "Quadruple-hit" primary testicular diffuse large B-cell lymphoma with MYD88 L265P mutation, IGH::MYC, and irf4- and BCL6-rearrangements.
Bruehl FK; Ketterling RP; Rimsza LM; Santos EF; McPhail ED
J Hematop; 2023 Sep; 16(3):161-165. PubMed ID: 38175404
[TBL] [Abstract] [Full Text] [Related]
5. Large B-cell lymphoma with irf4 rearrangement: a multi-centric study with focus on potential misleading phenotypes.
Pizzi M; Bongiovanni L; Lorenzi L; Righi S; Scarmozzino F; Balzarini P; Santoro L; Mussolin L; Carraro E; Pillon M; Bonaldi L; Vianello F; Agostinelli C; Ponzoni M; Dei Tos AP; Sabattini E
Virchows Arch; 2024 Mar; 484(3):521-526. PubMed ID: 37962684
[TBL] [Abstract] [Full Text] [Related]
6. Transcriptional reprogramming by mutated irf4 in lymphoma.
Schleussner N; Cauchy P; Franke V; Giefing M; Fornes O; Vankadari N; Assi SA; Costanza M; Weniger MA; Akalin A; Anagnostopoulos I; Bukur T; Casarotto MG; Damm F; Daumke O; Edginton-White B; Gebhardt JCM; Grau M; Grunwald S; Hansmann ML; Hartmann S; Huber L; Kärgel E; Lusatis S; Noerenberg D; Obier N; Pannicke U; Fischer A; Reisser A; Rosenwald A; Schwarz K; Sundararaj S; Weilemann A; Winkler W; Xu W; Lenz G; Rajewsky K; Wasserman WW; Cockerill PN; Scheidereit C; Siebert R; Küppers R; Grosschedl R; Janz M; Bonifer C; Mathas S
Nat Commun; 2023 Nov; 14(1):6947. PubMed ID: 37935654
[TBL] [Abstract] [Full Text] [Related]
7. DUSP22-irf4 Rearranged CD30-Positive Primary Cutaneous Lymphoproliferative Disorder With Gamma/Delta Phenotype.
Fattah YH; Crasto D; Liu SS; Linhares Y; Kerdel F; Hanly A; Karai LJ
Am J Dermatopathol; 2023 Dec; 45(12):831-834. PubMed ID: 37883980
[TBL] [Abstract] [Full Text] [Related]
8. Clinical boundaries in adult cases of large B cell lymphoma with irf4 rearrangement.
Maguire J; Harvey H; Jones A; Law R; Bashir M; O'Brien O; Sargent J; Grant C; Flavin R
Histopathology; 2024 Jan; 84(2):399-401. PubMed ID: 37876327
[TBL] [Abstract] [Full Text] [Related]
9. Evolution of lymphoma Diagnosis in the Era of Personalized Medicine: A Marriage of Pathology and Genomics for Clinical Practice.
Jaffe ES
Am J Pathol; 2023 Dec; 193(12):1880-1886. PubMed ID: 37734589
[TBL] [Abstract] [Full Text] [Related]
10. Genomic Profiling of Primary Diffuse Large B-Cell lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
Agostinelli C; Morandi L; Righi S; Cirillo L; Iommi M; Tonon C; Mazzatenta D; Zoli M; Rossi M; Bagnato G; Broccoli A; Lodi R; Zinzani PL; Sabattini E; Giannini C; Asioli S
Mod Pathol; 2023 Dec; 36(12):100323. PubMed ID: 37678673
[TBL] [Abstract] [Full Text] [Related]
11. T helper type 9 cell response and its role in the neurological clinic of patients with Human T-lymphotropic virus 1.
de Sena Rodrigues Júnior R; Antonia Nunes Gomes J; Alberto da Silva Dias G; Fujihara S; Toshimitsu Yoshikawa G; Vilela Lopes Koyama R; Catarina Medeiros Sousa R; Antonio Simões Quaresma J; Thais Fuzii H
Immunobiology; 2023 Nov; 228(6):152740. PubMed ID: 37657359
[TBL] [Abstract] [Full Text] [Related]
12. Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and irf4 rearrangements in adult patients.
Yuan J; Liu H; Hu S; Miranda RN; Xu X; Bayerl MG; Artymiuk CJ; Berg H; King RL; Shi M; He R; Viswanatha D; Medeiros LJ; McPhail ED
Hum Pathol; 2023 Nov; 141():22-29. PubMed ID: 37634651
[TBL] [Abstract] [Full Text] [Related]
13. Anaplastic Large Cell Transformation of Mycosis Fungoides: Case Report and Review of the Literature.
Flerova E; Alpdogan O; Bhatti S; Nikbakht N; Wang ZX; Gong JZ
Am J Dermatopathol; 2023 Sep; 45(9):e74-e82. PubMed ID: 37625813
[TBL] [Abstract] [Full Text] [Related]
14. [lymphomas in children and adolescents].
Klapper W
Pathologie (Heidelb); 2023 Nov; 44(6):338-347. PubMed ID: 37608069
[TBL] [Abstract] [Full Text] [Related]
15. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
Salaverria I; Weigert O; Quintanilla-Martinez L
Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
[TBL] [Abstract] [Full Text] [Related]
16. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with irf4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
[TBL] [Abstract] [Full Text] [Related]
17. Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
Rodriguez-Pinilla SM; Dojcinov S; Dotlic S; Gibson SE; Hartmann S; Klimkowska M; Sabattini E; Tousseyn TA; de Jong D; Hsi ED
Virchows Arch; 2024 Jan; 484(1):15-29. PubMed ID: 37530792
[TBL] [Abstract] [Full Text] [Related]
18. Targeting N-linked Glycosylation for the Therapy of Aggressive lymphomas.
Scheich S; Chen J; Liu J; Schnütgen F; Enssle JC; Ceribelli M; Thomas CJ; Choi J; Morris V; Hsiao T; Nguyen H; Wang B; Bolomsky A; Phelan JD; Corcoran S; Urlaub H; Young RM; Häupl B; Wright GW; Huang DW; Ji Y; Yu X; Xu W; Yang Y; Zhao H; Muppidi J; Pan KT; Oellerich T; Staudt LM
Cancer Discov; 2023 Aug; 13(8):1862-1883. PubMed ID: 37141112
[TBL] [Abstract] [Full Text] [Related]
19. Anaplastic large cell lymphomas with the 6p25.3 rearrangement are a heterogeneous group of tumours with a diverse molecular background.
Díaz de la Pinta FJ; Rodríguez Moreno M; Salgado RN; Carvajal García N; Santonja C; Pérez Buira S; Piris MA; Requena L; Manso R; Rodríguez-Pinilla SM
Hum Pathol; 2023 Jul; 137():71-78. PubMed ID: 37127078
[TBL] [Abstract] [Full Text] [Related]
20. irf4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B-cell lymphoma.
Jiang XN; Yu F; Xue T; Xia QX; Bai QM; Yu BH; Shui RH; Zhou XY; Zhu XZ; Cao JN; Hong XN; Li XQ
Cancer Med; 2023 May; 12(9):10684-10693. PubMed ID: 37081786
[TBL] [Abstract] [Full Text] [Related]
[Next]
